Clinical Trial Update: Clinical Study of TQB2868 Injection Combined With Anlotinib Capsule and Chemotherapy in the First-line Treatment of Metastatic Pancreatic Neoplasms [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial explores TQB2868 with Anlotinib and chemotherapy as first-line treatment for metastatic pancreatic cancer and is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Anlotinib (anlotinib)
• TQB2868

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Conditions: Pancreatic Neoplasms | Phase 2 | Status: RECRUITING